IGF-1 DES 1mg

IGF-1 DES is investigated in peptide signaling pathway research. A signaling pathway is a series of molecular interactions inside cells. These interactions help researchers understand how peptides bind to receptors.

Researchers study peptide–receptor interaction models. A receptor is a protein that binds to a specific molecule. Binding can trigger measurable cellular responses in controlled systems.

Controlled laboratory peptide stability studies are also conducted. Stability refers to how a compound maintains structure over time. These studies evaluate environmental factors such as temperature and light exposure.

This compound is used strictly for laboratory investigation. It supports structured experimental design in peptide research environments.

IGF-1 DES has been investigated in research environments focused on molecular signaling analysis. It is studied within controlled laboratory models that examine receptor-binding dynamics.

It is explored for experimental peptide research involving modified peptide sequences. A modified sequence means the amino acid structure has been adjusted. Researchers analyze how structural changes affect binding behavior.

This igf-1 des peptide peptide supports structured in-vitro experiments. In-vitro means studies performed outside a living organism. These are usually conducted in laboratory containers such as culture plates.

All investigations are performed by qualified professionals. Research parameters are defined by institutional protocols.

Store IGF-1 DES in cool, dry, light-protected conditions. Controlled refrigeration is recommended for long-term storage.

Laboratory handling only. This compound must be managed by qualified research personnel.

Avoid exposure to moisture and excessive heat. These factors may influence molecular stability.

Maintain sealed containment until experimental preparation begins. Use calibrated laboratory tools when preparing research materials.

Each batch undergoes purity verification procedures. Purity testing confirms molecular composition. High-performance liquid chromatography is commonly used. This method separates compounds to measure purity levels.

Mass spectrometry may be applied for identity confirmation. This technique measures molecular mass. It ensures structural accuracy.

Batch-to-batch consistency is documented. Analytical records are retained for review. Internal quality assurance standards guide production and release processes.

This product is positioned within the research peptide supply category. It is intended exclusively for scientific investigation. Quality control testing IGF-1 DES peptide protocols support reproducible research outcomes.

• CAS: 112603-35-7
• Chemical Formula: C₃₁₉H₅₀₁N₉₁O₉₆S₇
• Molecular Weight: 7371.48 g/mol
• Peptide Sequence: H-Thr-Leu-Cys-Gly-Ala-Glu-Leu-Val-Asp-Ala-Leu-Gln-Phe-Val-Cys-Gly-Asp-Arg-Gly-Phe-Tyr-Phe-Asn-Lys-Pro-Thr-Gly-Tyr-Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro-Gln-Thr-Gly-Ile-Val-Asp-Glu-Cys-Cys-Phe-Arg-Ser-Cys-Asp-Leu-Arg-Arg-Leu-Glu-Met-Tyr-Cys-Ala-Pro-Leu-Lys-Pro-Ala-Lys-Ser-Ala-OH
• Synonyms: IGF1 Human Des1-3; Insulin-Like Growth Factor 1 Des (1-3) Human Recombinant; Somatomedin C; IGF-I; IGFI; IGF1; IGF-IA; Des(1-3); Des1-3; Des 1-3; Des (1-3); IGF-1 (4-70); IGF1 Des1-3
• Shelf life: 24 months from the manufacturing date.

IGF-1 DES is a synthetic peptide. Synthetic means it is produced through controlled chemical synthesis rather than extracted from natural sources.

The term “short-acting peptide” refers to how long the compound remains active in a test system. Short-acting indicates a brief interaction window in laboratory models. This property is useful for time-dependent signaling research.

Modified peptide sequences are often studied in laboratory research. Structural changes may influence receptor binding patterns. Researchers examine these differences under controlled experimental conditions.

This igf-1 des peptide peptide is manufactured to defined molecular specifications. Analytical testing verifies molecular weight and structural identity.

• Short-acting research peptide formulation
• Low-quantity format for precise laboratory research
• High-purity, batch-tested compound
• Secure packaging and discreet shipment for laboratory supply chains

This IGF-1 DES peptide peptide is supplied in a compact 1mg format. The small format supports accurate measurement in laboratory settings. Each batch undergoes analytical review before release. Documentation is maintained for research records.

Packaging is sealed and light-protected. This supports compound stability during transport. Shipments are prepared for research institutions and professional laboratories.

IGF-1 DES (des(1-3)IGF-1) is a truncated variant of insulin-like growth factor 1 that lacks the first three N-terminal amino acids (Gly-Pro-Glu) present in the full-length 70-amino acid molecule. This truncation reduces its affinity for IGF-binding proteins (IGFBPs) while preserving full IGF-1 receptor binding capacity, making it a useful research tool for studying IGF-1R signalling in systems where IGFBP competition is a confounding variable.

IGF-1 DES activates the IGF-1 receptor tyrosine kinase, triggering autophosphorylation and recruitment of IRS-1/2 adaptor proteins. Downstream signalling branches studied in research models include PI3K/Akt (regulating cell survival and protein synthesis), MAPK/ERK (regulating proliferation), and mTORC1 (regulating anabolic metabolism). The reduced IGFBP binding of IGF-1 DES relative to full-length IGF-1 makes dose-response relationships in cell-based assays more predictable.

Common cell systems include muscle-derived cell lines (C2C12, L6), neuronal cell models, hepatocyte cultures, and cancer cell lines with defined IGF-1R expression levels. Receptor knockdown or knockout controls confirm IGF-1R specificity. Phosphospecific antibodies against Akt (Ser473), ERK1/2, and S6K1 provide standard downstream readouts of pathway activation following IGF-1 DES treatment.

Lyophilised IGF-1 DES should be stored at -20°C, protected from light and moisture. Reconstitution in 0.1% acetic acid or dilute acidic buffer maintains solubility; the solution should be further diluted into neutral buffer for cell-based applications. Single-use aliquots are recommended to avoid repeated freeze-thaw cycles, which reduce biological activity.

No. IGF-1 DES as supplied by Elivena is for research use in controlled laboratory settings only. It is not approved for therapeutic, performance, or clinical use outside of formally regulated contexts.